MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome

Di Perri, Dario;Hartgerink, D.;Terhaag, K.;Houben, R.;Eekers, D.;et.al.
(2023) ESTRO — Location: Vienna

Files

No attached file found for this publication.

Details

Authors
  • Di Perri, DarioUCLouvain
    Author
  • Hartgerink, D.
    Author
  • Terhaag, K.
    Author
  • Houben, R.
    Author
  • Eekers, D.
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Di Perri, D., Hartgerink, D., Terhaag, K., Houben, R., Compter, I., & Eekers, D. (2023). MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. ESTRO, Vienna.